Fortis Healthcare Ltd, India’s leading integrated healthcare delivery provider, SRL Diagnostics, India’s reputed Pathology Lab network, and NDTV, achieved yet another milestone by setting a GUINNESS WORLD RECORDS™ feat in the category of ‘Most Blood Glucose Level tests conducted in 8 hours’ (multiple venues).
On the occasion of the World Diabetes Day on 14th November, 2014, a record number of 10508 free Blood Sugar tests were conducted at select Fortis and SRL facilities including select onsite locations. The tests were conducted in partnership with SRL Labs, surpassing a previous Saudi Arabia record of 9,736 blood glucose tests, set in February 2013. The free walk-in tests were organized as part of a ‘NDTV Fortis Health4U’ campaign, encouraging people to make healthy lifestyle choices.
This is the fourth GUINNESS WORLD RECORDS™ title for Fortis Healthcare. The three previous titles include; the largest number of cervical screenings (751) conducted in 8 hours, the highest number (3039) of people sanitizing their hands simultaneously, at a single venue and the largest number of cholesterol blood tests (14,161), all achieved in 2012.
The Fortis facilities that were a part of the existing GUINNESS WORLD RECORDS™ challenge included, The Fortis Memorial Research Institute (FMRI) in Gurgaon, Fortis Noida, Shalimar Bagh and Fortis CDOC in Delhi NCR and Fortis Vashi, Mulund and S L Raheja in Mumbai. The participating SRL facilities were; SRL Preet Vihar in Delhi and SRL’s Central Reference Laboratory at Goregaon in Mumbai.
Speaking on the occasion, Ashish Bhatia, Chief Operating Officer, Fortis Healthcare, said, “We are pleased to add yet another record to the bouquet of our achievements with the GUINNESS WORLD RECORDS™. It is a matter of pride that our campaign to create awareness on prevention of diabetes is now globally recognized. We have always believed that the best care is possible by preventing illness and by shifting the emphasis from ‘treatment’ to ‘prevention’. We will continue to work closely with various stakeholders including consumers to spread awareness on, one of the most prevalent diseases in our society.”
"I’m delighted to announce Fortis Healthcare, SRL Diagnostics and NDTV have achieved a new Guinness World Records title for Most Blood Glucose Level tests. This is a fantastic achievement, the record will go in the history books and remain there for years to come”, said Richard Stenning, Guinness World Records Adjudicator.
Mr. Sanjeev Vashishta, CEO, SRL Diagnostics, India, said, "This benchmark for clinical excellence further encourages us to stay committed to delivering high quality services to our patients. In a nationwide endeavor to raise health awareness and to highlight the importance of regular health check-ups, we will continue to provide accurate and precise diagnostic, prognostic and predictive testing services in a timely manner through our state-of-the-art health facilities.”
Dr. Anoop Misra, Chairman, Fortis C-DOC Hospital for Diabetes, Metabolic Diseases and Endocrinology, said, “Our goal is to make India Diabetes free. It is a matter of concern that young people in the age group of 20-40 years are increasingly suffering from Diabetes. As leaders in healthcare, specifically diabetes, it is important for us to spread awareness regarding the benefits of a healthy lifestyle, while engaging consumers and stakeholders to take proactive steps towards early detection and treatment.”
The Fortis Health4U campaign attempts to make interventions at three levels. It focuses on Prevention and Lifestyle modifications with an emphasis on early diagnosis. The aim is to Equip and Empower people through life-skill trainings to promote Healthy Living as a way of life.
About Fortis Healthcare Limited
Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Singapore, Dubai, Mauritius and Sri Lanka with 55 healthcare facilities (including projects under development), approximately 10,000 potential beds and 270 diagnostic centers. In a global study of the 30 most technologically advanced hospitals in the world, its flagship, the Fortis Memorial Research Institute’ (FMRI), was ranked No.2, by ‘topmastersinhealthcare.com, and placed ahead of many other outstanding medical institutions in the world.
About SRL Diagnostics
SRL Diagnostics is one of the leading chains of Clinical Diagnostic Centers in India. The diagnostic centre was introduced with the vision of providing accurate solutions to the diagnosis of various diseases, with ethical standards and care as it core values. SRL Diagnostics has 275 laboratories, including 12 Reference Labs, 4 Centers of Excellence, 19 radiology/imaging centers, and a footprint spanning over 5700+ collection points. The company has large labs in Dubai, Sri Lanka and Nepal, and also about 50 collection points in various countries outside India.
SRL Diagnostics is the veritable pioneer of medical diagnostics in India. Established in 1995, the diagnostic center has been imbued with a mission to deliver Gold Standard Diagnostic services, both in the field of Laboratory Medicine and Radiology including hi-end Imaging services.
SRL has the most Accredited Lab Network in India comprising of 31 NABL accredited labs and 4 CAP accredited labs. SRL continues to revolutionalise diagnostic services in India by ushering in the most specialized technologies, and innovative services.
Its Research and Innovation division is ISO certified and was the first lab in the Private Sector which was recognized by the Government of India‘s Department of Scientific and Industrial Research. SRL’s wide range of tests provides quality diagnostic, prognostic and monitoring services to other path labs, hospitals and patients. It also provides services of testing samples for the Multinational and Indian Pharmaceutical companies/ CROs undertaking Phase III/ IV Clinical Trial work, thereby supporting their international regulatory submissions.
No comments:
Post a Comment